Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2023-03-21 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
111年第4季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a detailed consolidated cash flow statement for the fiscal year 111 (2022) Q4, with specific financial data such as net income, depreciation, changes in assets and liabilities, and cash flows from operating, investing, and financing activities. The presence of comprehensive financial statements and substantive financial data for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 2572 characters, which is relatively short but contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). FY 2022
2023-03-21 Chinese
111年第4季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial figures for the fiscal year 111 (2022) and the previous year 110 (2021). It includes revenue, costs, expenses, net income, and earnings per share data. The presence of actual financial data and detailed accounting items indicates this is a financial report rather than an announcement or summary. The document length is 2130 characters, which is relatively short, but the content is substantive financial data, not just a notice or certification. The document is a quarterly or interim financial report because it covers a specific quarter (fourth quarter of year 111) and includes detailed financial statements. Therefore, the appropriate classification is Interim / Quarterly Report (IR). FY 2022
2023-03-21 Chinese
111年第4季資產負債表
Interim / Quarterly Report Classification · 90% confidence The document contains a consolidated balance sheet with detailed financial data for two fiscal year-end dates (December 31, 2022 and December 31, 2021). It includes asset, liability, and equity breakdowns with monetary amounts and percentages. The presence of comprehensive financial statements for a full fiscal year period indicates this is a formal financial report. The document length is 3145 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. The content matches the characteristics of an Interim / Quarterly Report (IR) because it is for the fourth quarter of the year (Q4 2022), not a full annual report (10-K). There is no indication this is an announcement or a certification, nor is it a summary or presentation. Therefore, the best classification is Interim / Quarterly Report (IR). FY 2022
2023-03-21 Chinese
111年度股利金額(董事會決議)
Notice of Dividend Amount Classification · 100% confidence The document text is a detailed table and explanation regarding dividend distribution for a company, including cash dividends, stock dividends, and related shareholder meeting dates. It includes specific dividend amounts, dates of board resolutions and shareholder meetings, and notes on legal and regulatory requirements for dividend distribution. This type of document is an announcement of dividend amounts and payment details to shareholders. It does not contain full financial statements or comprehensive financial performance data, so it is not an Annual Report or Interim Report. It is not a proxy solicitation or voting results announcement. The content matches the definition of a Notice of Dividend Amount (DIV). The document length is under 5,000 characters and is focused on dividend distribution details, confirming the classification as DIV.
2023-03-21 Chinese
112年2月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 科妍, providing information about fund loans and endorsement guarantees for the current and previous month, with amounts all zero. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and loans, without any detailed financial statements, management discussion, or regulatory certifications. It does not contain any narrative or detailed financial results, nor does it announce or attach a report. This type of document is a regulatory disclosure of financial status related to guarantees and loans, typical of a general regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS).
2023-03-08 Chinese
112年2月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a brief summary table of monthly and cumulative net operating revenue figures for a company named 科妍, with comparisons to the previous year and percentage changes. It includes notes explaining accounting standards and reporting practices. The document length is very short (760 characters) and contains no detailed financial statements, management discussion, or comprehensive analysis. It is essentially a revenue summary report, typical of a brief financial factsheet or summary. There is no indication that this is an announcement of a report publication or a regulatory filing. Given the concise nature and focus on key financial figures, this fits best as a Fund Information / Factsheet (FS) type document, which is a brief summary of key company facts and financials.
2023-03-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.